These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 4972506)
1. [Therapeutic results of betahistine on Meniere's disease. Multi-variable analysis of the results of the double blind test and Fisher's evaluation method]. Okamoto K; Hazeyama F; Taira T; Yoshida A; Onoda T Iryo; 1968 May; 22(5):650-66. PubMed ID: 4972506 [No Abstract] [Full Text] [Related]
2. [Evaluation of the effect of betahistine in Meniere's disease by double-blind test and multivariate analysis]. Watanabe K; Fukami J; Yoshimoto H; Ueda M; Suzuki J Jibiinkoka; 1967 Nov; 39(11):1237-50. PubMed ID: 4969849 [No Abstract] [Full Text] [Related]
3. Long-term office treatment of Meniere's disease. Martins JK Eye Ear Nose Throat Mon; 1969 Jul; 48(7):410-2. PubMed ID: 4978414 [No Abstract] [Full Text] [Related]
5. Modification of the vestibular function with betahistine HCl. Bertrand RA Laryngoscope; 1971 Jun; 81(6):889-98. PubMed ID: 4997046 [No Abstract] [Full Text] [Related]
6. [Initial findings in the treatment of Meniere's disease with betahistine hydrochloride (Betaserc)]. Segers JM Acta Otorhinolaryngol Belg; 1972; 26(2):262-8. PubMed ID: 4626970 [No Abstract] [Full Text] [Related]
7. A study of the efficacy of betahistine in Méniére's syndrome. Hommes OR Acta Otolaryngol Suppl; 1972; 305():70-9. PubMed ID: 4353751 [No Abstract] [Full Text] [Related]
8. The effect of betahistine hydrochloride in Méniére's disease. Wilmot TJ Acta Otolaryngol Suppl; 1972; 305():18-21. PubMed ID: 4353748 [No Abstract] [Full Text] [Related]
9. Méniére's disease: subjective and objective evaluation of medical treatment with betahistine HCl. Bertrand RA Acta Otolaryngol Suppl; 1972; 305():48-69. PubMed ID: 4353750 [No Abstract] [Full Text] [Related]
10. An objective study of the effect of betahistine hydrochloride on hearing and vestibular function tests in patients with Ménière's disease. Wilmot TJ J Laryngol Otol; 1971 Apr; 85(4):369-73. PubMed ID: 4995451 [No Abstract] [Full Text] [Related]
11. [Study of a programmed release preparation of betahistine mesylate in the treatment of Ménière's disease (author's transl)]. Pialoux P Ann Otolaryngol Chir Cervicofac; 1981; 98(9):483-6. PubMed ID: 7041769 [TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of medical treatment for Menière's disease, using a double-blind controlled study. Mizukoshi K; Watanabe I; Matsunaga T; Hinoki M; Komatsuzaki A; Takayasu S; Tokita T; Matsuoka I; Matsunaga T; Tanaka T Am J Otol; 1988 Sep; 9(5):418-22. PubMed ID: 3202132 [TBL] [Abstract][Full Text] [Related]
17. Meniere's disease. (Preliminary report of a new treatment). Guay RM Appl Ther; 1970 Aug; 12(8):25-7. PubMed ID: 4990325 [No Abstract] [Full Text] [Related]
18. [Treatment of Meniere disease with betahistine dimesilate (Aequamen)--double-blind study versus placebo (crossover)]. Meyer ED Laryngol Rhinol Otol (Stuttg); 1985 May; 64(5):269-72. PubMed ID: 3894841 [TBL] [Abstract][Full Text] [Related]
19. Controlled clinical trial comparing the effect of betahistine hydrochloride and prochlorperazine maleate on patients with Meniére's disease. Aantaa E; Skinhoj A Ann Clin Res; 1976 Aug; 8(4):284-7. PubMed ID: 793500 [TBL] [Abstract][Full Text] [Related]
20. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study]. Kluyskens P; Lambert P; D'Hooge D Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]